A few misconceptions tend to follow discussions of pharmaceutical products Mexico. One is assuming there’s nothing to verify: in reality, the market includes domestic Mexican manufacturers alongside Mexican subsidiaries of multinational drug companies. Another common assumption gets the details backwards on cost or convenience, when in fact prices tend to run lower than in the U.S. because Mexico’s pricing and patent-enforcement system works differently. A third misunderstanding overlooks a practical detail that matters more than people expect: checking a manufacturer’s name against COFEPRIS’s public registry is a quick way to confirm legitimacy. Clearing up these points ahead of time makes for a much more informed approach to pharmaceutical products Mexico.